From: Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
RRMS relapse | NIND | RRMS relapse vs NIND | |||||||
---|---|---|---|---|---|---|---|---|---|
Mean CT | N | Median (IQR) | CSF/PBMC p-value | N | Median (IQR) | CSF/PBMC p-value | p-value | q-value | |
CD3d PBMC NR | 31.1 | 15 | 0.06 (0.04 to 0.08) | 10 | 0.05 (0.04 to 0.07) | 0.47 | 0.26 | ||
CD3d CSF NR | 35.6 | 13 | 0.10 (0.08 to 0.23) | 10 | 0.06 (0.02 to 0.15) | 0.07 | 0.09 | ||
CD3d CSF/PBMC Ratio | 11 | 2.37 (1.30 to 3.67) | 0.01 | 10 | 1.12 (0.42 to 3.07) | 0.39 | 0.23 | 0.17 | |
CD14 PBMC NR | 30.1 | 15 | 0.33 (0.27 to 0.38) | 10 | 0.33 (0.29 to 0.49) | 0.38 | 0.23 | ||
CD14 CSF NR | 34.9 | 13 | 0.38 (0.07 to 0.52) | 10 | 1.52 (0.94 to 2.40) | 0.0004 | 0.01 | ||
CD14 CSF/PBMC Ratio | 11 | 1.39 (0.30 to 2.15) | 0.42 | 10 | 4.01 (3.54 to 5.16) | 0.01 | 0.003 | 0.02 | |
CD19 PBMC NR | 36.1 | 15 | 0.14 (0.09 to 0.23) | 10 | 0.08 (0.05 to 0.16) | 0.05 | 0.09 | ||
CD19 CSF NR | 37.1 | 13 | 0.00 (0.00 to 0.35) | 10 | 0.00 (0.00 to 0.00) | 0.03 | 0.09 | ||
CD19 CSF/PBMC Ratio | 11 | 0.00 (0.00 to 0.89) | 10 | 0.00 (0.00 to 0.00) | 0.04 | 0.09 | |||
CD56 PBMC NR | 34.9 | 15 | 0.15 (0.09 to 0.23) | 10 | 0.16 (0.07 to 0.32) | 0.96 | 0.43 | ||
CD56 CSF NR | 37.8 | 13 | 0.00 (0.00 to 0.03) | 10 | 0.00 (0.00 to 0.00) | 0.11 | 0.10 | ||
CD56 CSF/PBMC Ratio | 11 | 0.00 (0.00 to 0.00) | 10 | 0.00 (0.00 to 0.00) | 0.17 | 0.14 |